DNA Capital

Investor type

PE / VC

Founded

2013

AUM

-

Location

Brazil

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Series B

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector. Our mission is to invest in and provide strategic value to the best companies and founding teams in healthcare. Our team is multidisciplinary, deeply rooted in healthcare and passionate about finding and helping the best companies to thrive.

Industry

Business Services (B2B) Fintech Healthcare Services Education Edtech Fashion/Beauty Financial Services Medical Devices Pharmaceuticals MedTech Life Sciences Infrastructure HealthTech

Region of investment

North America South America

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
Ws4KSo1iEbvH6ln8 Ws4KSo1iEbvH6ln8
Ws4KSo1iEbvH6ln8
avatar
Ws4KSo1iEbvH6ln8 Ws4KSo1iEbvH6ln8
Ws4KSo1iEbvH6ln8
avatar
Ws4KSo1iEbvH6ln8 Ws4KSo1iEbvH6ln8
Ws4KSo1iEbvH6ln8
avatar
Ws4KSo1iEbvH6ln8 Ws4KSo1iEbvH6ln8
Ws4KSo1iEbvH6ln8
avatar
Ws4KSo1iEbvH6ln8 Ws4KSo1iEbvH6ln8
Ws4KSo1iEbvH6ln8
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about DNA Capital

DNA Capital is located in Brazil.
DNA Capital was founded in 2013.
DNA Capital invests in companies and startups in Business Services (B2B), Fintech, Healthcare Services, Education, Edtech, Fashion/Beauty, Financial Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, Infrastructure, HealthTech.
DNA Capital invests in companies and startups in North America, South America.
DNA Capital invests in companies and startups at Series B.
DNA Capital usually invests $1-5 m on average.